Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal ...

Forte Minerals Corp., a mining exploration company, engages in the acquisition, exploration, and development of copper and gold projects in Peru. It explores for gold, copper, and molybdenum ...

Forte Minerals Corp. is pleased to announce that its common shares will begin trading on the OTCQB under the symbol "FOMNF" as of the opening of the market on April 7 th, 2022. In conjunction with ...